AZAMIAN BOBAK R. (President and CEO) sold 1.2% of their position (10K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $905.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/9/2026ACC: 0001827672-26-000013
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
-10K
Net shares
Net seller
$905.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−7.10K
Price / share
$90.27
Trade value
$640.92K
% of position
0.8%
9/4/2026
837.99K→830.89K
Common Stock
Indirect
Shares
−2.90K
Price / share
$91.27
Trade value
$264.68K
% of position
0.3%
9/4/2026
830.89K→827.99K
Total
Net shares
−10K
Net value
-$905.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/4/2026 | S · Sale | −7.10K | $90.27 | $640.92K | 0.8% | 837.99K | 830.89K |
| Common Stock Indirect | 9/4/2026 | S · Sale | −2.90K | $91.27 | $264.68K | 0.3% | 830.89K | 827.99K |
| Total | −10K | -$905.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned33.42K
Total
33.42K direct33.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 33.42K | Direct |
| Total | 33.42K | 33.42K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported